Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
FDA/EMA/Drug Designation
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
FDA/EMA/Drug Designation
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
FDA/EMA/Drug Designation
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
FDA/EMA/Drug Designation
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
FDA/EMA/Drug Designation
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
FDA/EMA/Drug Designation
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Firstwordpharma News
-
January 10, 2021
FDA/EMA/Drug Designation
Mexico to get 400,000-500,000 Pfizer vaccines a week into March, president says – FirstWord Pharma
FDA/EMA/Drug Designation
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA – FirstWord Pharma
FDA/EMA/Drug Designation
Denmark close to securing enough Covid-19 vaccines for entire population – FirstWord Pharma
FDA/EMA/Drug Designation
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration – FirstWord Pharma
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
FDA/EMA/Drug Designation
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint...
Firstwordpharma News
-
January 10, 2021
0
FDA/EMA/Drug Designation
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial...
Firstwordpharma News
-
January 10, 2021
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
1
2
3
...
131
Page 1 of 131
- Advertisement -
MOST POPULAR
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
May 13, 2019
Poxel Reports Financial Update for Cash and Revenue for the Second...
July 15, 2019
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
October 30, 2020
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint...
January 10, 2021
Load more
HOT NEWS
Others
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of...
Clinical
IQVIA Report: Spending on Drugs Globally to Exceed $1.1 Trillion by...
Ophthalmology
On World Sight Day, Allergan Launches National Campaign to Raise Awareness...
Commercial
Auris Medical Announces Reverse Stock Split
